Generation of an Enriched Pool of DNA Aptamers for a HER2 Overexpressing Cell Line selected by Cell –SELEX
نویسنده:
, , , , , , ,سال
: 2011
چکیده: Overexpression of human epidermal growth factor receptor 2
(HER2) occurs in a large percentage of breast cancers.
Monoclonal antibodies targeting HER2 are vastly used for both
diagnostic and therapeutic aims. However, identifying a new
molecular probe against HER2 with improved diagnostic and
therapeutic features is of great importance. In this report, we
have applied the cell systematic evolution of ligands by
exponential enrichment (SELEX) strategy for 16 selection
rounds to generate an enriched pool of aptamers that
specifically recognize the HER2 positive cell line. During the
Cell SELEX procedure, a human HER2-overexpressing breast
cancer cell line and a human HER2 negative breast cancer cell
line were used. Our results reveal that polymerase chain
reaction (PCR) amplification of random DNA libraries and the
selected single-stranded DNA pool in different Cell SELEX
rounds are different from what we expect from PCR
amplification of homologous DNA. Our results also confirmed
previous studies describing positive HER2 status of SK-BR3
and the absence of the HER2 expression in the MDA-MB468.
We also developed a new method, Cell enzyme-linked assay,
to monitor the enrichment of aptamers in a given round of Cell
SELEX. This method would also be useful in other experiments
using live cell enzyme-linked immunosorbent assay on
adherent cells.
(HER2) occurs in a large percentage of breast cancers.
Monoclonal antibodies targeting HER2 are vastly used for both
diagnostic and therapeutic aims. However, identifying a new
molecular probe against HER2 with improved diagnostic and
therapeutic features is of great importance. In this report, we
have applied the cell systematic evolution of ligands by
exponential enrichment (SELEX) strategy for 16 selection
rounds to generate an enriched pool of aptamers that
specifically recognize the HER2 positive cell line. During the
Cell SELEX procedure, a human HER2-overexpressing breast
cancer cell line and a human HER2 negative breast cancer cell
line were used. Our results reveal that polymerase chain
reaction (PCR) amplification of random DNA libraries and the
selected single-stranded DNA pool in different Cell SELEX
rounds are different from what we expect from PCR
amplification of homologous DNA. Our results also confirmed
previous studies describing positive HER2 status of SK-BR3
and the absence of the HER2 expression in the MDA-MB468.
We also developed a new method, Cell enzyme-linked assay,
to monitor the enrichment of aptamers in a given round of Cell
SELEX. This method would also be useful in other experiments
using live cell enzyme-linked immunosorbent assay on
adherent cells.
کلیدواژه(گان): Keywords: aptamer,breast cancer,Cell ELA,Cell SELEX,HER2
کالکشن
:
-
آمار بازدید
Generation of an Enriched Pool of DNA Aptamers for a HER2 Overexpressing Cell Line selected by Cell –SELEX
Show full item record
contributor author | کاظم دستجردی | en |
contributor author | غلامرضا هاشمی تبار | en |
contributor author | حسام دهقانی | en |
contributor author | علیرضا حق پرست | en |
contributor author | Kazem Dastjerdi | fa |
contributor author | GHOLAMREZA HASHEMI TABAR | fa |
contributor author | Hesam Dehghani | fa |
contributor author | Alireza Haghparast | fa |
date accessioned | 2020-06-06T14:36:08Z | |
date available | 2020-06-06T14:36:08Z | |
date issued | 2011 | |
identifier uri | https://libsearch.um.ac.ir:443/fum/handle/fum/3403575 | |
description abstract | Overexpression of human epidermal growth factor receptor 2 (HER2) occurs in a large percentage of breast cancers. Monoclonal antibodies targeting HER2 are vastly used for both diagnostic and therapeutic aims. However, identifying a new molecular probe against HER2 with improved diagnostic and therapeutic features is of great importance. In this report, we have applied the cell systematic evolution of ligands by exponential enrichment (SELEX) strategy for 16 selection rounds to generate an enriched pool of aptamers that specifically recognize the HER2 positive cell line. During the Cell SELEX procedure, a human HER2-overexpressing breast cancer cell line and a human HER2 negative breast cancer cell line were used. Our results reveal that polymerase chain reaction (PCR) amplification of random DNA libraries and the selected single-stranded DNA pool in different Cell SELEX rounds are different from what we expect from PCR amplification of homologous DNA. Our results also confirmed previous studies describing positive HER2 status of SK-BR3 and the absence of the HER2 expression in the MDA-MB468. We also developed a new method, Cell enzyme-linked assay, to monitor the enrichment of aptamers in a given round of Cell SELEX. This method would also be useful in other experiments using live cell enzyme-linked immunosorbent assay on adherent cells. | en |
language | English | |
title | Generation of an Enriched Pool of DNA Aptamers for a HER2 Overexpressing Cell Line selected by Cell –SELEX | en |
type | Journal Paper | |
contenttype | External Fulltext | |
subject keywords | Keywords: aptamer | en |
subject keywords | breast cancer | en |
subject keywords | Cell ELA | en |
subject keywords | Cell SELEX | en |
subject keywords | HER2 | en |
journal title | Biotechnology and Applied Biochemistry | fa |
pages | 226-230 | |
journal volume | 58 | |
journal issue | 4 | |
identifier link | https://profdoc.um.ac.ir/paper-abstract-1023013.html | |
identifier articleid | 1023013 |